RE: Rainbow11 Sep 2025 12:19
I have been holder of AEP and agree with you. Also thinking about another poster mentioning inclusion in UK FTSE 250. I asked Grok to look into it - after asking it to analyse AEP, and looking at the buy backs since 11 Augustus. So for what it's worth - see below. (I did fact check that market cap is correct, and Grok used 1065p as closing price 11th August 2025, however, I'm not knowledgeable at all about the Russell rules. So be aware for hallucinations). I had to summarize.
BEGIN Yes, inclusion in the FTSE 250 looks quite realistic in the near term, particularly around the upcoming September 2025 review (effective post-close on September 20, 2025, for the December rebalance). Here is a breakdown based on the latest data as of early September 2025:
AEP.L Market Cap: Approximately £483 million (based on ~39.49 million shares outstanding at ~1,220p close on September 10). This reflects the ~15% uplift since the buyback launch, with the program reducing shares by ~0.5% so far (negligible EPS accretion yet, but supportive).
Current Index Classification: AEP.L is presently in the FTSE SmallCap index (part of the broader FTSE All-Share), ranking around 339th in the All-Share by investable market cap as of September 2. This places it just inside the top 350 but on the cusp—FTSE 250 covers ranks 101-350.
FTSE 250 Thresholds: The smallest constituents in the FTSE 250 currently hover around £442-443 million .
From FTSE Russell's 2025 ground rules:
Size (Investable Market Cap): Primary driver—must rank in the top 350 of the FTSE All-Share. AEP's current ranking (339th) positions it for potential fast-track or standard entry, especially if the buyback sustains the price hover/support.
Free Float: Minimum 10% for UK-domiciled firms (AEP qualifies as a UK PLC). AEP's is ~95% (high institutional ownership but ample float).
Liquidity: Requires median daily trading volume covering 0.4% of shares monthly (tested over 8-12 months). AEP's average volume (~5,000-10,000 shares/day) meets this for small-caps, bolstered by buyback activity.
Other: UK-quoted (Main Market), no investment trusts, and non-sterling lines now eligible from September 2025 (but AEP is GBP-denominated).
Risks Volatility: CPO prices dip, buyback pauses early, risking rank slippage to 351+. Competition: ~10-15 slots turn over quarterly; Timing: September review locks in changes for December 23 effective date—too late for immediate Q4 boost, but sets up 2026 momentum.
In summary, with the cap already above the bottom quartile of the 250 and catalysts aligned, I'd peg odds at 70-80% for inclusion by year-end. END